GSK plc (GSK) stock analysis

In our weekly check, GSK plc is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2.

About GSK plc

GSK plc is a Healthcare company (Drug Manufacturers - General) based in the United Kingdom, listed on NYSE as GSK.

What our checks show for GSK

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-03

Similar companies

SNY · BMY · PFE · NVO · GILD · AMGN

Questions

What grade does GSK plc (GSK) have?

In our weekly check, GSK plc is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of GSK stock?

This week's biggest flags for GSK plc: Margins falling, Slow recovery after falls, High debt. In total 8 of 25 checks show a warning or a red flag.

What does GSK plc do?

GSK plc is a Healthcare company (Drug Manufacturers - General) based in the United Kingdom, listed on NYSE as GSK.

When does GSK plc report earnings next?

The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis